Researchers have found in a new research that deucravacitinib significantly improves joint pain and musculoskeletal symptoms ...

Both men and women with psoriasis are equally at risk for developing psoriatic arthritis (PsA)—a chronic inflammatory ...

The exact cause of psoriatic arthritis isn't known, but the immune system plays a major role in its development. In general, ...

Understand how psoriatic arthritis increases heart disease risk through inflammation. Learn management tips for heart health, from lifestyle changes to medication discussions.

In July 2025, Janssen Research & Development LLC conducted a study is to evaluate the efficacy of icotrokinra compared to ...

Patients with psoriatic arthritis with a family history of psoriatic disease are diagnosed with psoriasis and psoriatic ...

Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common symptoms of psoriatic arthritis include joint pain, swelling, and stiffness.

The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.

Over 80% of people diagnosed with psoriatic arthritis experience psoriasis first, with joint problems typically appearing 7-10 years later.

Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects the joints and skin, causing pain, stiffness and swelling. This condition often occurs in people who have psoriasis, an ...

Self-care methods for psoriatic arthritis (PsA) include staying active with gentle exercises, getting enough sleep, and ...

I’d been living with psoriasis since 1998, so I knew the data: 30% of people with psoriasis go on to develop psoriatic arthritis. But so much time had passed that I truly thought the comorbidity ...